Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: immune Clear Filter

Gene-edited pancreatic cells transplanted into a patient with type 1 diabetes

Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or even to change the color of a spider’s web. But the greatest hope is that this technology will help find a cure for a global disease, such as diabetes. A new study points in that direction. For the first time, researchers succeeded in implanting Crispr-edited pancreatic cells in a man with type 1 diab

CRISPR offers new hope for treating diabetes

Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or even to change the color of a spider’s web. But the greatest hope is that this technology will help find a cure for a global disease, such as diabetes. A new study points in that direction. For the first time, researchers succeeded in implanting Crispr-edited pancreatic cells in a man with type 1 diab

CRISPR Offers New Hope for Treating Diabetes

Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or even to change the color of a spider’s web. But the greatest hope is that this technology will help find a cure for a global disease, such as diabetes. A new study points in that direction. For the first time, researchers succeeded in implanting Crispr-edited pancreatic cells in a man with type 1 diab

Crispr Offers New Hope for Treating Diabetes

Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or even to change the color of a spider’s web. But the greatest hope is that this technology will help find a cure for a global disease, such as diabetes. A new study points in that direction. For the first time, researchers succeeded in implanting Crispr-edited pancreatic cells in a man with type 1 diab

Immunotherapy drug clinical trial results: half of tumors shrink or disappear

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously systemic inflammatory responses, low platelet counts, and liver toxicity, among other adverse reactions—even at a low dose. But in 2018, the lab of Rockefeller University’s Jeffrey V. Ravetch

Immunotherapy drug eliminates aggressive cancers in clinical trial

Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously systemic inflammatory responses, low platelet counts, and liver toxicity, among other adverse reactions—even at a low dose. But in 2018, the lab of Rockefeller University’s Jeffrey V. Ravetch

One-shot vaccines for HIV and covid

Irvine and MIT professor J. Christopher Love, the senior authors of a paper on the work, had found that the combination helped generate more robust immune responses. In the new paper, they showed that the dual-adjuvant vaccine accumulated in the lymph nodes, where white blood cells known as B cells encounter antigens and undergo rapid mutations that generate new antibodies. The vaccine’s antigens remained there for up to a month, allowing the immune system to build up a much greater number and d

5 Tips Doctors Swear By to Keep Your Kids Healthy This School Year

With back-to-school season almost here, there's lots of pressure to make sure your kids have all their supplies on hand. However, another thing you have to look out for is potential illness. According to the US Centers for Disease Control and Prevention, in 2022, almost 6% of students aged 5 to 17 had chronic absenteeism in school due to illness, injury or disability. Even kids who don’t have chronic absenteeism can miss a day or two because they catch something in the classroom. Dr. Markyia Ni

Best Immunity Supplements for 2025

CNET staff -- not advertisers, partners or business interests -- determine how we review products and services. If you buy through our links, we may earn a commission. There's nothing worse than getting sick, and it only gets easier if you don't have a great immune system. One of the best ways to boost your immune system health is to stick to a healthy diet and keep active, particularly throughout the cold and flu season. But, of course, if you're looking to help your system even further, there

Diabetic Man With Gene-Edited Cells Produces His Own Insulin—No Transplant Drugs Required

A new case study offers a tantalizing glimpse into the potential future of transplantation medicine. A man with type 1 diabetes is now able to make his own insulin thanks to a transplant of gene-edited pancreatic cells—a transplant that hasn’t required the typical drugs used to avoid rejection. Scientists in Sweden and the U.S. conducted the research, published this week in the New England Journal of Medicine. The 42-year-old man with long-standing diabetes was given donated islet cells that we